Testing effectiveness (Phase 2)Active Not RecruitingNCT02547987What this trial is testingNeoadjuvant Carboplatin and Docetaxel in Triple Negative Breast CancerWho this might be right forBreast Cancer Mothaffar Rimawi 25
Not applicableWithdrawnNCT07136493What this trial is testingCirculating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+4 more City of Hope Medical Center
Not applicableLooking for participantsNCT07206121What this trial is testingFeasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving SurgeryWho this might be right forBreast CancerBreast-conserving SurgeryBreast Cancer - Infiltrating Ductal Carcinoma+2 more Innoblative Designs, Inc. 10
Not applicableEnded earlyNCT03137693What this trial is testingPreoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast CancerWho this might be right forBreast CancerBreast Cancer FemaleBreast Adenocarcinoma H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT02746328What this trial is testingAdd-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body MassWho this might be right forER+ and AR+ Breast Cancer GTx
Testing effectiveness (Phase 2)Study completedNCT00721409What this trial is testingStudy Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast CancerWho this might be right forBreast Cancer Pfizer 177
Testing effectiveness (Phase 2)WithdrawnNCT03326258What this trial is testingGlembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by SurgeryWho this might be right forAdvanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more National Cancer Institute (NCI)
Very early researchWithdrawnNCT00993642What this trial is testingERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast CancerWho this might be right forBreast Cancer Tulane University Health Sciences Center
Not applicableWithdrawnNCT01292083What this trial is testingAzacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By SurgeryWho this might be right forRecurrent Breast CancerStage IA Breast CancerStage IB Breast Cancer+6 more University of Southern California
Large-scale testing (Phase 3)Active Not RecruitingNCT04961996What this trial is testingA Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)Who this might be right forEarly Breast Cancer Hoffmann-La Roche 4,170
Testing effectiveness (Phase 2)UnknownNCT04334330What this trial is testingPalbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in ChinaWho this might be right forBreast CancerBrain Metastases Sun Yat-sen University 34
Testing effectiveness (Phase 2)WithdrawnNCT00252811What this trial is testingZD1839 Effects on Cell Proliferation in Breast CancerWho this might be right forBreast Cancer AstraZeneca 60
Not applicableStudy completedNCT01027416What this trial is testingAnalyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer PatientsWho this might be right forBreast Cancer Roswell Park Cancer Institute 59
Testing effectiveness (Phase 2)Ended earlyNCT00194792What this trial is testingHormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+3 more University of Washington 28
Early research (Phase 1)Study completedNCT01594398What this trial is testingStudy to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung CancerWho this might be right forLung CancerNon Small Cell Lung Cancer (NSCLC)Breast Cancer+1 more Syndax Pharmaceuticals 14
Early research (Phase 1)WithdrawnNCT02619669What this trial is testingNeoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast CancerWho this might be right forBreast Cancer Gary Schwartz
Testing effectiveness (Phase 2)Study completedNCT01698918What this trial is testingOpen-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast CancerWho this might be right forHormone Receptor Positive Breast Cancer Novartis Pharmaceuticals 202
Testing effectiveness (Phase 2)Study completedNCT00134680What this trial is testingLetrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBCWho this might be right forMetastatic Breast Cancer Duke University 33
Testing effectiveness (Phase 2)UnknownNCT04236310What this trial is testingNeoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer.Who this might be right forBreast CancerHER2-positive Breast CancerER-positive Breast Cancer Ruijin Hospital 37
Large-scale testing (Phase 3)Study completedNCT00433589What this trial is testingGenetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesWho this might be right forBreast Cancer European Organisation for Research and Treatment of Cancer - EORTC 6,600